GPT and anemia (phenotype): Other recorded adverse events included hand-foot syndrome (10.0%), aspartate aminotransferase increase (10.0%), anorexia (7.5%), alanine aminotransferase increase (5.0%), anemia (5.0%), peripheral neurotoxicity (5.0%), rash (2.5%) and thrombocytopenia (2.5%).